(AmericanProsperity.com) – Healthcare companies are racing to create and mass-produce a coronavirus vaccine. The most promising trials received some monetary assistance from the government. However, one company already has $400 million in customer deposits.
Moderna’s COVID-19 vaccine trial is currently in Phase 3. Once approved, it plans to price the vaccine between $32 and $37 per dose for small orders. Larger volume orders could be cheaper.
— Moderna (@moderna_tx) August 5, 2020
The Phase 1 report, released in mid-July, shows “high levels of neutralizing antibody activity against the coronavirus.” While this is optimistic, over 40% of participants who received larger doses developed a fever after the vaccine’s second dose, and over 20% of participants who received the largest dose reported severe systemic symptoms.
Moderna already received $1.6 billion in government grants to support this research effort. With all of the money already committed to this vaccine, we must ensure it’s safe and effective before it’s distributed to the masses.
~Here’s to Your Prosperity!
Copyright 2020, AmericanProsperity.com